|
|
||||||||
CUTTING EDGE |


*
Division of Molecular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121;
Department of Immunology and Microbiology, Rush Medical College, Chicago, IL 60612;
Department of Medicine, University of California at San Diego, La Jolla CA 92093; and
§
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
The UL144 open reading frame found in clinical isolates of human CMV (HCMV) encodes a structural homologue of the herpesvirus entry mediator, a member of the TNFR superfamily. UL144 is a type I transmembrane glycoprotein that is expressed early after infection of fibroblasts; however, it is retained intracellularly. A YXXZ motif in the highly conserved cytoplasmic tail contributes to UL144 subcellular distribution. The finding that no known ligand of the TNF family binds UL144 suggests that its mechanism of action is distinct from other known viral immune evasion genes. Specific Abs to UL144 can be detected in the serum of a subset of HCMV seropositive individuals infected with HIV. This work establishes a novel molecular link between the TNF superfamily and herpesvirus that may contribute to the ability of HCMV to escape immune clearance.
This article has been cited by other articles:
![]() |
T. Crough and R. Khanna Immunobiology of Human Cytomegalovirus: from Bench to Bedside Clin. Microbiol. Rev., January 1, 2009; 22(1): 76 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Benedict, A. Loewendorf, Z. Garcia, B. R. Blazar, and E. M. Janssen Dendritic Cell Programming by Cytomegalovirus Stunts Naive T Cell Responses via the PD-L1/PD-1 Pathway J. Immunol., April 1, 2008; 180(7): 4836 - 4847. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Stanton, B. P. McSharry, C. R. Rickards, E. C. Y. Wang, P. Tomasec, and G. W. G. Wilkinson Cytomegalovirus Destruction of Focal Adhesions Revealed in a High-Throughput Western Blot Analysis of Cellular Protein Expression J. Virol., August 1, 2007; 81(15): 7860 - 7872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Wills, O. Ashiru, M. B. Reeves, G. Okecha, J. Trowsdale, P. Tomasec, G. W. G. Wilkinson, J. Sinclair, and J. G. P. Sissons Human Cytomegalovirus Encodes an MHC Class I-Like Molecule (UL142) That Functions to Inhibit NK Cell Lysis J. Immunol., December 1, 2005; 175(11): 7457 - 7465. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim and Y. Kliger Discovering hidden viral piracy Bioinformatics, December 1, 2005; 21(23): 4216 - 4222. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Griffin, E. C. Y. Wang, B. P. McSharry, C. Rickards, H. Browne, G. W. G. Wilkinson, and P. Tomasec Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18 J. Gen. Virol., November 1, 2005; 86(11): 2999 - 3008. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Watts and J. L. Gommerman The LIGHT and DARC sides of herpesvirus entry mediator PNAS, September 20, 2005; 102(38): 13365 - 13366. [Full Text] [PDF] |
||||
![]() |
T. C. Cheung, I. R. Humphreys, K. G. Potter, P. S. Norris, H. M. Shumway, B. R. Tran, G. Patterson, R. Jean-Jacques, M. Yoon, P. G. Spear, et al. From The Cover: Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway PNAS, September 13, 2005; 102(37): 13218 - 13223. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Picone, J.-M. Costa, M.-L. Chaix, Y. Ville, C. Rouzioux, and M. Leruez-Ville Human Cytomegalovirus UL144 Gene Polymorphisms in Congenital Infections J. Clin. Microbiol., January 1, 2005; 43(1): 25 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy, I. Rigoutsos, T. Shibuya, and T. E. Shenk Reevaluation of human cytomegalovirus coding potential PNAS, November 11, 2003; 100(23): 13585 - 13590. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. A. van der Strate, J. L. Hillebrands, S. S. Lycklama a Nijeholt, L. Beljaars, C. A. Bruggeman, M. J. A. van Luyn, J. Rozing, T. H. The, D. K. F. Meijer, G. Molema, et al. Dissemination of Rat Cytomegalovirus through Infected Granulocytes and Monocytes In Vitro and In Vivo J. Virol., October 15, 2003; 77(20): 11274 - 11278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Baillie, D. A. Sahlender, and J. H. Sinclair Human Cytomegalovirus Infection Inhibits Tumor Necrosis Factor Alpha (TNF-{alpha}) Signaling by Targeting the 55-Kilodalton TNF-{alpha} Receptor J. Virol., June 15, 2003; 77(12): 7007 - 7016. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Gamadia, E. B. M. Remmerswaal, J. F. Weel, F. Bemelman, R. A. W. van Lier, and I. J. M. Ten Berge Primary immune responses to human CMV: a critical role for IFN-gamma -producing CD4+ T cells in protection against CMV disease Blood, April 1, 2003; 101(7): 2686 - 2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Y. Wang, B. McSharry, C. Retiere, P. Tomasec, S. Williams, L. K. Borysiewicz, V. M. Braud, and G. W. G. Wilkinson From the Cover: UL40-mediated NK evasion during productive infection with human cytomegalovirus PNAS, May 28, 2002; 99(11): 7570 - 7575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Moise, J. R. Grant, T. Z. Vitalis, and W. A. Jefferies Adenovirus E3-6.7K Maintains Calcium Homeostasis and Prevents Apoptosis and Arachidonic Acid Release J. Virol., February 15, 2002; 76(4): 1578 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Gamadia, R. J. Rentenaar, P. A. Baars, E. B. M. Remmerswaal, S. Surachno, J. F. L. Weel, M. Toebes, T. N. M. Schumacher, I. J. M. ten Berge, and R. A. W. van Lier Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers Blood, August 1, 2001; 98(3): 754 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saraiva and A. Alcami CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses J. Virol., January 1, 2001; 75(1): 226 - 233. [Abstract] [Full Text] |
||||
![]() |
N. S. Lurain, K. S. Kapell, D. D. Huang, J. A. Short, J. Paintsil, E. Winkfield, C. A. Benedict, C. F. Ware, and J. W. Bremer Human Cytomegalovirus UL144 Open Reading Frame: Sequence Hypervariability in Low-Passage Clinical Isolates J. Virol., December 1, 1999; 73(12): 10040 - 10050. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |